INTRODUCTION
Ventricular tachyarrhythmias are the most common cause of sudden cardiac death (SCD). Among ventricular tachyarrhythmias, primary and secondary ventricular fibrillation represent the major causes of SCD (Bayés de Luna, Coumel, & Leclercq, 1989) . Cardiopulmonary resuscitation may preserve brain function and prevent end organ damage temporarily; however, the only effective treatment for ventricular fibrillation is prompt electrical defibrillation. Implantable cardioverter-defibrillators (ICDs) are more effective than anti-arrhythmic agents for the secondary prevention of SCD, especially after a previous life-threatening cardiac event. ("A Comparison of AntiarrhythmicDrug Therapy," 1997; Akhtar et al., 1993; Connolly et al., 2000; Kuck, Cappato, Siebels, & Rüppel, 2000) . Evidence has supported the use of ICDs as a treatment modality for secondary prevention in patients with a history of ventricular tachycardia, ventricular fibrillation, or successful resuscitation from SCD, and for primary prevention in patients at severe risk for developing ventricular tachycardia, ventricular fibrillation, or both (Epstein et al., 2008) .
Significant causes of ventricular tachycardia and ventricular fibrillation are the congenital cardiac channelopathies, including long QT syndrome (LQTS), Brugada syndrome (BS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and short QT syndrome (SQTS). Cardiac channelopathies, inherited in an autosomal dominant pattern with variable penetrance, present with a range of phenotypes. Channelopathies are potentially lethal, with reports of 6% to 13% of individuals with LQTS experiencing cardiac arrest or SCD before the age of 40 if not treated (Modell & Lehmann, 2006) . Many patients are asymptomatic until their initial clinical manifestation of sudden death. In addition, 25% of patients with LQTS have "concealed" phenotypes in which they are at risk for cardiac arrhythmias but do not have prolonged QT intervals on electrocardiograms (Goldenberg et al., 2011) . Cardiac channelopathies produce ventricular tachyarrhythmias via the abnormal conduction of ions through affected ion channels responsible
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Background: Cardiac ion channelopathies are a wellrecognized cause of sudden cardiac death in infants, children, adolescents, and young adults. ICDs are effective in preventing sudden death from fatal arrhythmias in patients with known cardiac channelopathies. There is a paucity of research on the effect of ICDs on quality of life in patients with cardiac channelopathy diagnoses, especially young patients.
Methods: A qualitative study interviewing patients and families affected by inherited arrhythmias was conducted. Fifty participants with personal or family histories of cardiac events or sudden death were interviewed individually or in focus groups by clinical psychologists. All interviews were transcribed verbatim and then analyzed and coded based on current qualitative research theory to identify themes related to the research question. Twenty-four participants discussed ICDs in their interviews.
Perceptions of Implantable Cardioverter-Defibrillators ORIGINAL ARTICLE for depolarizing and repolarizing the cardiac myocyte cell membrane, resulting in abnormal electrical conductance throughout the heart. These channel abnormalities are inherited as gain-of-function or loss-of-function mutations in families, placing first-degree relatives of affected individuals at considerable risk of inheriting the same genetic mutations. Therefore, genetic testing has emerged as a useful screening tool for identifying cardiac channelopathies in patients and their families with a strong clinical suspicion of this diagnosis (Boussy et al., 2010) .
Evidence suggests that LQTS, BS, CPVT, and SQTS are significant causes of SIDS and SUDS (Arnestad et al., 2007; Tester & Ackerman, 2009) . Sudden infant death syndrome (SIDS) is defined as the sudden death of a child under the age of 12 months with no identifiable medical cause after a thorough investigation. Sudden unexplained death syndrome (SUDS) refers to the unexplained death of a person between the ages of 1 and 25, 30, 35, or 40 (depending upon the source). Sudden unexplained death in childhood (SUDC) applies to the sudden death of a child between the ages of 1 and 18. Therapy for cardiac channelopathies often involves primary and secondary prevention of ventricular tachyarrhythmias through the implantation of ICDs, along with beta blocker therapy and lifestyle modification (Kaufman, 2009) .
Complication rates related to ICDs have been reported at approximately 30%. Surgical complications, generatorrelated problems, lead complications, and inappropriate shocks have been identified as the most common complications (Alter, Waldhans, Plachta, Moosdorf, & Grimm, 2005) . Similar complications have been identified in the pediatric population, with the addition of a significant psychosocial impact on patients' lives (Shah, 2009 ).
There is a paucity of research investigating the effect of ICDs on the quality of life of patients with cardiac channelopathy diagnoses, especially young patients. As part of a larger qualitative study of patients and families primarily affected by inherited arrhythmias to investigate the ethical and social issues associated with genetic testing, we performed a secondary analysis on the impact of ICDs. In their comments, participants often spontaneously raised issues related to ICDs. A secondary analysis of the data identified themes associated with ICDs. This study identifies important topics for healthcare providers to discuss with their patients living with or considering ICD placement.
METHODS

Recruitment of Families
This study is an analysis of comments voiced by a subset (24 out of 50) of the subjects enrolled in the Montefiore Einstein Center for CardioGenetics' study on the ethical issues raised by the translation of genetic knowledge into clinical practice. The subjects were chosen for the subset if they spontaneously mentioned ICDs in their interviews or focus groups. The original study focused on evaluating and organizing ethical, legal, and social issues associated with cardiogenetic diseases linked to potentially fatal cardiac arrhythmias (Barlevy et al., 2012; Cohen et al, 2012) . Fifty participants were interviewed individually or in focus groups to learn about their subjective experience of having a cardiogenetic disease. Associated ethical and social issues were evaluated. All participants in the study had histories, either personal or family, of cardiac events with clinical diagnoses of cardiac arrhythmia, or of relatives who had died from SIDS or SUDS.
The study population was recruited from three different sources: patients being cared for at the Montefiore Einstein Center for CardioGenetics ( n = 27); respondents to an invitation posted in a newsletter from the Sudden Unexplained Death in Childhood Program ( n = 9); and respondents to an invitation posted in a newsletter from the Sudden Arrhythmia Death Syndromes Foundation ( n = 14). Prior to study participation, each recruited individual provided written informed consent and completed a questionnaire containing demographic information. The study protocol was reviewed and approved by the Institutional Review Board of Albert Einstein College of Medicine/Montefiore Medical Center.
Interviews and Transcription
All interviews and focus groups were conducted by clinical psychologists either in person or over the telephone. Open-ended questions were used to promote discussion about participants' experiences with cardiac arrhythmias or sudden death. Focus groups were composed of two or more unrelated individuals. Interviews were conducted with individuals and family units. All interviews and focus groups were recorded with audio devices and were subsequently transcribed verbatim. Transcripts were de-identified to protect participants' privacy. For the present study, comments were identified and extracted that were specifically relevant to the participants' experiences with ICDs.
Coding and Analysis of Transcripts
The transcripts from this study as well as the parent study were analyzed by the grounded theory approach developed by Auerbach and Silverstein (2003) . This approach groups regularly used words and phrases from different interviews or focus groups into repeating ideas, and then groups these similar repeating ideas into themes, further describing the research question.
Statistical Analysis
A chi-square test was performed comparing the subjects included in the ICD study to the subjects excluded from the study.
RESULTS AND DISCUSSION
Participant Population and Demographics Demographic information for the entire population and the participants who discussed ICDs is provided in Table  1 . Thirty-nine women and 11 men participated in the overall study, and 21 women and three men discussed ICDs. A chi-square analysis was performed comparing ICD discussants and nondiscussants, and the populations were found to be similar. Among those who discussed ICDs, two participants had diagnoses of Brugada syndrome, 19 participants had diagnoses of long QT syndrome, two participants had diagnoses of short QT syndrome, and one participant did not have a diagnosis. Of these participants, 10 had undergone ICD implantation, while 14 had not. Among those participants who had not elected to have ICDs placed, 42% were parents of children with ICDs and were intricately involved in the decision-making process (Table 2) .
Identified Themes
Multiple themes were identified during the discussion. Themes identified include comprehension and physicianpatient communication, anxiety, complications, restrictions and fallacies, utility, and alternative therapy (Table 3 -5).
Many ICDs were implanted in participants during or after emergency situations in which the participants had experienced life-threatening arrhythmias. During these circumstances, participants often expressed fear of the emergency surgery and noted that they were unsure of what was happening:
"The last thing I remember is turning on the TV to watch a movie. Another issue raised by participants involved communication with medical staff. Many participants expressed dissatisfaction when asking hospital staff to listen and comply with their decisions. One member of a family who was well known to the hospital staff due to the previous loss of a child from SUDS commented: Parents voiced concerns when their children were affected by channelopathies and had defibrillators. Sources of anxiety in this situation included guilt and the question of communicating with children. Caregivers expressed guilt about passing the disease on to their children, and many participants discussed the desire to undergo genetic testing for family-planning purposes. Additionally, parents described feelings of anxiety that events might occur and they would not be present to take care of their children. Explaining to children why they needed ICDs was often difficult. Parents were anxious about affected children running, jumping, and playing competitive sports, and even explaining to their children the reasons for their anxiety was worrisome to many: Much of the focus on anxiety has been on that felt by patients and parents, but it is important to remember that cardiac channelopathies affect the entire family. Many participants expressed having strong support systems in their families and many of these close relatives and family friends expressed anxiety as well:
"She gets scared her device is gonna go off, so I'll go over there, but I'm scared. When she sleeps, she shakes. I'm constantly making sure she's okay or waking her up. I'm scared sometimes to be with her by myself." Female, age unknown
Receiving ICDs was a life-changing experience for participants. Not only did the participants undergo surgery and live with the worry of arrhythmogenic events and device firing, but they were no longer able to participate in many activities that they had previously. Participants described restrictions on their regular exercise habits, which was emotionally difficult for many. They also talked about being unable to go through metal detectors or obtain MRI scans. The inability to have an MRI scan affected one participant who was misdiagnosed with Brugada syndrome and is now believed to have a seizure disorder:
"R had an MRI, which was his one and only, and now he will never have an MRI [again] because the leads will be in his body forever. I think most people think a seizure is a seizure when it actually could be the heart. It is very rarely reversed." Female, age 58
Participants also described a notion that others do not and cannot fully understand the implications of living with ICDs. Participants' quality of life changed, and many individuals had to modify their lifestyles and plan to be close to medical facilities at all times in the event that arrhythmias requiring ICD firing should occur.
Some participants expressed beliefs concerning ICDs that are not necessarily true. One patient often expressed fear that using a cell phone would prevent his device from working properly:
"My mom has a defibrillator. Many participants mentioned ICDs in the context of complications they experienced secondary to ICD implantation. Complications described included a serious infection that required device explantation, and a fractured device lead shortly after initial surgical implantation requiring explantation with a second device implantation. Many participants described problems with battery life and the need for multiple surgeries every five to seven years. Participants expressed concern over recurrent surgeries, and regardless of the number of procedures required, they commented that it never got easier: Because of the lifestyle restrictions and complications associated with ICD placement, many participants reported dissatisfaction with the devices. Most commonly their disappointment was with device utility, meaning that during the time when many patients had their devices implanted, they never required an appropriate defibrillation shock. Although this could be considered positive, given the invasiveness of the initial and subsequent procedures and the implications for quality of life, patients were at times ambivalent about their decision to have ICDs implanted:
"Are you glad you got the defibrillator?" "[I]f it ever saves my life, I'll say 'Yes.' Considering it's never had to shock me yet, I can't say 'Yes' and I can't say 'No.'" Female, age 38
One participant found meditation extremely helpful in reducing the anxiety surrounding her heart condition, especially given her decision not to undergo device implantation. CONCLUSION Participants in this study reported recurrent issues when discussing ICDs, including comprehension and physicianpatient communication, anxiety, complications, restrictions and fallacies, utility, and alternative therapy. These results were similar to many of the findings in the current literature examining the quality-of-life implications of ICD implantation (Eckert & Jones, 2002; Kamphuis, de Leeuw, Derksen, Hauer, & Winnubst, 2003; Syska et al., 2010; Wójcicka, Lewandowski, Smolis-Bak, & Szwed, 2008) .
Our findings include many that are consistent with those of previous studies. A qualitative study by Anderson and colleagues focusing on the impact of living with a diagnosis of LQTS identified several important themes, including concern for family members, limitations in their daily lives, and a lack of understanding within a medical community fraught with uncertainty, misinformation, and inaccurate advice regarding clinical management (Andersen, Øyen, Bjorvatn, & Gjengedal, 2008) .
The psychological ramifications of living with ICDs have been studied, representing the heart-disease population at large. Patients with severe heart disease who require ICD implantation often suffer from co-morbid depression. In patients affected by co-morbid depression at implantation, depression persists in 72% of patients post-implantation. Patients with clinical depression and ICDs are at increased risk of shocks (36%) compared with nondepressed patients (9%) (Suzuki et al., 2010) . In a longitudinal study following patients with ICDs over four years, mental-health scores and overall psychological health scores improved significantly, while overall quality-of-life scores remained stable after device implantation (Carroll & Hamilton, 2008) . Two studies identified younger age at implantation as a significant risk factor for the development of clinical depression and anxiety as well as worsening quality of life Thomas et al., 2006) . A recent study by Probst and colleagues found that patients diagnosed with Brugada syndrome reported that ICDs have a negative social impact on their lives (Probst et al., 2011) .
One study examining physicians' views of their patients' quality of life post-implantation found that 47% of patients reported the same quality of life and 15% reported worsening quality of life with significant emotional and relationship strain. Furthermore, physicians reported discomfort in providing emotional and psychological support to their ICD patients, indicating the need for improved communication and encouragement from providers caring for patients with ICDs (Sears et al., 2000) . In a randomized trial evaluating the use of ICD patient education and cognitive behavioral therapy, patients were less anxious, had lower cortisol levels, and reported increased acceptance of their ICDs after the intervention, further supporting the need for improved physician-patient communication in patients with ICDs (Sears et al., 2007) .
Our study identified communication breakdown as a major cause of distress among patients receiving ICDs. Communication issues were not addressed in the published literature. Patients expressed their desire to have the opportunity to discuss ICDs prior to implantation, and in cases where this did not occur, more complications and dissatisfaction resulted. If immediate implantation was required, family members, especially caregivers, desired that they be informed about the reasons for device implantation and allowed to voice their concerns to ease anxiety, especially during emergency situations. This suggests that the need for an ICD, the mechanism of action of the ICD, and all risks and benefits of the procedure should be addressed prior to implantation, if possible. It is important not only to be effective communicators, but to be effective listeners as well. Although some patients were uneducated regarding their illness, others were extremely well informed. Patients and families were capable of comprehending these illnesses when provided with the appropriate tools, and their wishes should be respected as long as the patients or the healthcare proxies provided appropriate justification for decisions.
Many participants were ambivalent about their ICDs. Although the ICDs had been placed to protect them against fatal arrhythmias, many of the devices had never fired. This frustrated many participants, and a similar result was reported in a study by Sherrid and Daubert (2008) ; discussing, prior to implementation, the possibility that the ICDs would never fire might help ease patients' negative feelings long after undergoing implantation. Much of the literature reports contentment with ICDs regardless of firing; however, Sherrid and Daubert's study, like the present study, examined ICD perceptions in a younger patient population (Kamphuis et al., 2004; Sherrid & Daubert, 2008; Wójcicka et al., 2008) . It is possible that patients who are younger and suffering from cardiac channelopathies with minimal symptoms have different outlooks on their health status and the utility of device placement when compared to older patients suffering from congestive heart failure and its associated symptoms. More research is needed in this area to confirm this assertion.
It is important, when providing care to patients with ICDs, to identify those patients who are at increased risk of developing anxiety or depression. Thomas and colleagues identified patients with ICDs and the following characteristics to be at increased risk of developing psychiatric disorders: younger patients, patients who had experienced shocks in the past, and patients who reported current psychological distress or a prior history of psychological distress . Since the patient population affected by hereditary cardiac channelopathies is typically younger at age of implantation when compared to the total population of patients with ICDs, this population is inherently at higher risk for developing anxiety, depression, or both. Therefore, screening and treatment for anxiety and depression should be addressed in the care of patients with ICDs.
It is not clear how best to prevent the development of substantial mood disorders in patients and promote positive communication and outlooks. In a randomized clinical trial, patients with ICDs were provided with ICD education and cognitive behavioral therapy for their devices. These patients had reduced physiological levels of cortisol, less psychological distress, and improvements in quality of life (Sears et al., 2000; Sears et al., 2007) . This study, like others, identified problem-focused, optimistic coping strategies as the most useful in patients with chronic diseases and patients with ICDs (Flemme, Johansson, & Strömberg, 2012; Hallas, Burke, White, & Connelly, 2010; Kristofferzon, Löfmark, & Carlsson, 2005; Lindqvist, Carlsson, & Sjödén, 2004) . In addition, holistic practices may be of use in this patient population for easing stress, as exemplified by the meditation exercise described by one participant in this Given the small sample size and the subanalysis of a larger study, the results of this study are difficult to generalize. However, the results reflect similar findings in the current literature and are suggestive of issues surrounding ICDs that more patients may experience. It is also possible that participants who offered opinions regarding their ICDs more often had negative experiences regarding their own or a family member's ICD. Only one participant included in this subanalysis of the study was less than 21 years of age, making the generalizability to children of this study's findings difficult; however, given the concerns of the parents in this study and this one child, it is likely that other families experience similar concerns. The small sample size and number of participants from a specific geographical region, as well as the large representation of female participants compared with male participants, limit the generalizability of these findings. Additionally, self-reporting is prone to reporter bias. However, the themes identified in this study likely represent concepts and concerns shared by many other patients with ICDs, and should be useful in aiding healthcare providers in their discussions with patients who have ICDs or are contemplating ICD implantation. We offer a final set of suggestions in an effort to improve patient clarity concerning cardiogenetic disease (Table 6 ).
